CTOs on the Move


 
361md - a leading healthcare IT Company, represents a complete 360 degree solution for hospitals, doctors' offices, expert physicians, diagnostic labs, pharmacies, health insurance companies and other healthcare providers including nursing homes and rehab facilities.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.361md.com
  • 212 Middle Neck Road
    Great Neck, NY USA 11021
  • Phone: 877.333.6163

Executives

Name Title Contact Details

Similar Companies

Cuyuna Regional Medical Center

The Cuyuna Regional Medical Center is testimony to the positive, can-do spirit of the people and physicians of the17 communities of the beautiful lake country of eastern Crow Wing County, Minnesota. Create an environment where great doctors and a superb staff of medical professionals can practice the caliber of medicine they studied for. Give the people of the region the best possible healthcare. Never stop looking for ways to improve. Located on the Medical Campus at Crosby, the Cuyuna Regional Medical Center has established a rich tradition for innovation and progress in advancing the quality of healthcare in rural settings.

Stratis Health

Stratis Health is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delta Regional Medical Center

Delta Regional Medical Center has been committed to serving the citizens of Washington County and the outlying areas since our founding in the 1950s. Over time we have grown and progressed into a state-of-the-art hospital with a number of specialty

D1 Sports Training and Therapy

D1 Sports Training and Therapy is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.